Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN14884558Phase 4Completed
Phase 4, randomised trial of pentoxifylline in obesity and endothelial dysfunction, sponsored by University of Leeds. Primary endpoint: Flow mediated dilatation of brachial artery. Started Dec 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN14884558.